Business Description
CK Life Sciences International Holdings Inc
NAICS : 541711
ISIN : KYG2176J1058
Description
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 1.42 | |||||
| Debt-to-EBITDA | 12.18 | |||||
| Interest Coverage | 0.69 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.25 | |||||
| Beneish M-Score | -2.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.5 | |||||
| 3-Year EBITDA Growth Rate | 9.9 | |||||
| 3-Year FCF Growth Rate | 12.9 | |||||
| 3-Year Book Growth Rate | -3.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.4 | |||||
| 9-Day RSI | 44.29 | |||||
| 14-Day RSI | 41.71 | |||||
| 6-1 Month Momentum % | -47.06 | |||||
| 12-1 Month Momentum % | -53.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.42 | |||||
| Quick Ratio | 0.85 | |||||
| Cash Ratio | 0.32 | |||||
| Days Inventory | 124.92 | |||||
| Days Sales Outstanding | 66.07 | |||||
| Days Payable | 47.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.69 | |||||
| 3-Year Dividend Growth Rate | -7.2 | |||||
| Forward Dividend Yield % | 2.69 | |||||
| 5-Year Yield-on-Cost % | 2.3 | |||||
| Shareholder Yield % | 6.23 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.76 | |||||
| Operating Margin % | 4.21 | |||||
| Net Margin % | 0.32 | |||||
| FCF Margin % | 9.65 | |||||
| ROE % | 0.41 | |||||
| ROA % | 0.15 | |||||
| ROIC % | 0.53 | |||||
| ROC (Joel Greenblatt) % | 9.43 | |||||
| ROCE % | 4.79 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 167.5 | |||||
| PE Ratio without NRI | 167.5 | |||||
| Price-to-Owner-Earnings | 47.86 | |||||
| PS Ratio | 0.61 | |||||
| PB Ratio | 0.77 | |||||
| Price-to-Tangible-Book | 3.55 | |||||
| Price-to-Free-Cash-Flow | 6.32 | |||||
| Price-to-Operating-Cash-Flow | 6.32 | |||||
| EV-to-EBIT | 21.8 | |||||
| EV-to-EBITDA | 17.5 | |||||
| EV-to-Revenue | 1.6 | |||||
| EV-to-FCF | 16.58 | |||||
| Price-to-Projected-FCF | 0.71 | |||||
| Price-to-Median-PS-Value | 0.44 | |||||
| Earnings Yield (Greenblatt) % | 4.59 | |||||
| FCF Yield % | 15.97 | |||||
| Forward Rate of Return (Yacktman) % | 3.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CK Life Sciences International Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 626.056 | ||
| EPS (TTM) (€) | 0 | ||
| Beta | -0.52 | ||
| Volatility % | 34.82 | ||
| 14-Day RSI | 41.71 | ||
| 14-Day ATR (€) | 0.001613 | ||
| 20-Day SMA (€) | 0.036175 | ||
| 12-1 Month Momentum % | -53.71 | ||
| 52-Week Range (€) | 0.0315 - 0.0895 | ||
| Shares Outstanding (Mil) | 9,611.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CK Life Sciences International Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CK Life Sciences International Holdings Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
CK Life Sciences International Holdings Inc Frequently Asked Questions
What is CK Life Sciences International Holdings Inc(FRA:LSI)'s stock price today?
The current price of FRA:LSI is €0.03. The 52 week high of FRA:LSI is €0.09 and 52 week low is €0.03.
When is next earnings date of CK Life Sciences International Holdings Inc(FRA:LSI)?
The next earnings date of CK Life Sciences International Holdings Inc(FRA:LSI) is .
Does CK Life Sciences International Holdings Inc(FRA:LSI) pay dividends? If so, how much?
The Dividend Yield %  of CK Life Sciences International Holdings Inc(FRA:LSI) is 2.69% (As of Today), Highest Dividend Payout Ratio of CK Life Sciences International Holdings Inc(FRA:LSI) was 4. The lowest was 0.27. And the median was 0.46. The  Forward Dividend Yield % of CK Life Sciences International Holdings Inc(FRA:LSI) is 2.69%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers